AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 12077570 — intervention group
Group type: COMPARATOR
Intervention: Placebo treatment
Number of subjects: 49
Study 10072667 — intervention group
Group type: EXPERIMENTAL
Intervention: Imipramine
Number of subjects: 0
Study 10072667 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexnafenodone
Number of subjects: 0
Study 10072667 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 8545744 — intervention group
Group type: EXPERIMENTAL
Intervention: Single doses of 1,600, 2,400, and 3,200 mg of hypoxoside (standardised Hypoxis plant extract, 200 mg capsules)
Number of subjects: 24
Study 8545744 — intervention group
Group type: EXPERIMENTAL
Intervention: Multiple doses of 2,400 mg of hypoxoside (4 capsules 3 times daily for 11 days)
Number of subjects: 24
Study 2253931 — intervention group
Group type: EXPERIMENTAL
Intervention: Lactitol (36.3 g +/- 5 daily)
Number of subjects: 14
Study 2253931 — intervention group
Group type: COMPARATOR
Intervention: Lactulose (38.2 g +/- 19 daily)
Number of subjects: 14
Study 2253931 — intervention group
Group type: EXPERIMENTAL
Intervention: Lactitol
Number of subjects: 14
Study 2253931 — intervention group
Group type: COMPARATOR
Intervention: Lactulose
Number of subjects: 14
Study 6155064 — intervention group
Group type: EXPERIMENTAL
Intervention: Acetylprocainamide
Number of subjects: 16
Study 6155064 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16
Study 30910563 — intervention group
Group type: EXPERIMENTAL
Intervention: Active, intensive, repetitive upper limb training using the SMART Arm device 5 days a week for 5 weeks
Number of subjects: 50
Study 30910563 — intervention group
Group type: COMPARATOR
Intervention: Usual upper limb therapy 5 days a week for 5 weeks
Number of subjects: 50
Study 28862982 — intervention group
Group type: EXPERIMENTAL
Intervention: 1000 mg metformin administration
Number of subjects: 26
Study 26144895 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 μg HB vaccine in Group A
Number of subjects: 506
Study 26144895 — intervention group
Group type: EXPERIMENTAL
Intervention: 5 μg HB vaccine in Group C
Number of subjects: 506
Study 26144895 — intervention group
Group type: COMPARATOR
Intervention: 5 μg HB vaccine in Group B
Number of subjects: 506
Study 23881448 — intervention group
Group type: COMPARATOR
Intervention: Physical training
Number of subjects: 70
Study 23881448 — intervention group
Group type: COMPARATOR
Intervention: Cognitive training
Number of subjects: 70
Study 23881448 — intervention group
Group type: COMPARATOR
Intervention: Combined physical plus cognitive training
Number of subjects: 70
Study 23881448 — intervention group
Group type: COMPARATOR
Intervention: Waiting control group
Number of subjects: 70
Study 22509319 — intervention group
Group type: EXPERIMENTAL
Intervention: MTZ-Clind (oral metronidazole 400 mg bid + 2% vaginal clindamycin-cream)
Number of subjects: 450
Study 22509319 — intervention group
Group type: EXPERIMENTAL
Intervention: MTZ-Prob (oral metronidazole 400 mg bid + Lactobacillus acidophilus vaginal-probiotic)
Number of subjects: 450
Study 22509319 — intervention group
Group type: COMPARATOR
Intervention: MTZ-Placebo (oral metronidazole 400 mg bid + placebo)
Number of subjects: 450
Study 20021683 — intervention group
Group type: EXPERIMENTAL
Intervention: Medical Emergency Teams (METs)
Number of subjects: 0
Study 20021683 — intervention group
Group type: COMPARATOR
Intervention: Control hospitals
Number of subjects: 0
Study 17318804 — intervention group
Group type: EXPERIMENTAL
Intervention: Radiofrequency-assisted liver resection (RF-R)
Number of subjects: 50
Study 17318804 — intervention group
Group type: COMPARATOR
Intervention: Clamp-crushing method
Number of subjects: 50
Study 15385356 — intervention group
Group type: EXPERIMENTAL
Intervention: Cisatracurium 0.2 mg/kg based on real body weight (RBW) in Group I (n = 10)
Number of subjects: 20
Study 15385356 — intervention group
Group type: COMPARATOR
Intervention: Cisatracurium based on RBW in the control group (n = 10)
Number of subjects: 20
Study 15385356 — intervention group
Group type: EXPERIMENTAL
Intervention: Cisatracurium based on ideal body weight (IBW) in Group II (n = 10)
Number of subjects: 20
Study 11251623 — intervention group
Group type: EXPERIMENTAL
Intervention: Rofecoxib (1.5-25.0 mg for 5 consecutive days)
Number of subjects: 12
Study 11251623 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study 10481816 — intervention group
Group type: EXPERIMENTAL
Intervention: Not available
Number of subjects: 0
Study 7604691 — intervention group
Group type: EXPERIMENTAL
Intervention: Chronic female alcoholics
Number of subjects: 15
Study 7604691 — intervention group
Group type: COMPARATOR
Intervention: Healthy controls
Number of subjects: 15
Study 2337059 — intervention group
Group type: EXPERIMENTAL
Intervention: Olsalazine 3.0 g/day
Number of subjects: 15
Study 2337059 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15
Study 2337059 — intervention group
Group type: EXPERIMENTAL
Intervention: Olsalazine (open label after placebo)
Number of subjects: 15
Study 2337059 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall Olsalazine treatment
Number of subjects: 15
Study 10328033 — intervention group
Group type: EXPERIMENTAL
Intervention: 720 mg trimethoprim plus 3,600 mg sulfamethoxazole
Number of subjects: 50
Study 10328033 — intervention group
Group type: COMPARATOR
Intervention: 3.5 g ampicillin plus 1 g probenecid
Number of subjects: 50
Study 30692839 — intervention group
Group type: COMPARATOR
Intervention: Instrument-assisted soft tissue mobilization (IASTM)
Number of subjects: 40
Study 30692839 — intervention group
Group type: COMPARATOR
Intervention: Proprioceptive neuromuscular facilitation (PNF)
Number of subjects: 40
Study 30692839 — intervention group
Group type: EXPERIMENTAL
Intervention: Static stretching
Number of subjects: 40
Study 26848934 — intervention group
Group type: EXPERIMENTAL
Intervention: Bolus calculator (Cb group)
Number of subjects: 70
Study 26848934 — intervention group
Group type: COMPARATOR
Intervention: Active control (Co group)
Number of subjects: 70
Study 26131753 — intervention group
Group type: EXPERIMENTAL
Intervention: Arteriovenous coupler therapy
Number of subjects: 0
Study 26131753 — intervention group
Group type: COMPARATOR
Intervention: Normal care
Number of subjects: 0
Study 23205722 — intervention group
Group type: EXPERIMENTAL
Intervention: Contingency group (n = 35)
Number of subjects: 67
Study 23205722 — intervention group
Group type: COMPARATOR
Intervention: Prescription group (n = 32)
Number of subjects: 67
Study 21309874 — intervention group
Group type: EXPERIMENTAL
Intervention: 30% glucose
Number of subjects: 30
Study 21309874 — intervention group
Group type: COMPARATOR
Intervention: Sterile water
Number of subjects: 30
Study 19859935 — intervention group
Group type: EXPERIMENTAL
Intervention: T(1Gd)
Number of subjects: 0
Study 19859935 — intervention group
Group type: EXPERIMENTAL
Intervention: DeltaR(1)
Number of subjects: 0
Study 17565920 — intervention group
Group type: EXPERIMENTAL
Intervention: Brimonidine 0.15%
Number of subjects: 43
Study 14579918 — intervention group
Group type: EXPERIMENTAL
Intervention: Simvastatin 20 mg/day
Number of subjects: 42
Study 14579918 — intervention group
Group type: EXPERIMENTAL
Intervention: Simvastatin 40 mg/day
Number of subjects: 42
Study 10375203 — intervention group
Group type: EXPERIMENTAL
Intervention: Alendronate (10 mg/day)
Number of subjects: 307
Study 10375203 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of BAP levels and percent BAP change at 6 months
Number of subjects: 307
Study 10375203 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination model
Number of subjects: 307
Study 10375203 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 307
Study 8887578 — intervention group
Group type: EXPERIMENTAL
Intervention: Tiotropium 10 microg
Number of subjects: 12
Study 8887578 — intervention group
Group type: EXPERIMENTAL
Intervention: Tiotropium 40 microg
Number of subjects: 12
Study 8887578 — intervention group
Group type: EXPERIMENTAL
Intervention: Tiotropium 80 microg
Number of subjects: 12
Study 8887578 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study 1286471 — intervention group
Group type: EXPERIMENTAL
Intervention: Placebo treatment (n = 15)
Number of subjects: 24
Study 1286471 — intervention group
Group type: COMPARATOR
Intervention: Non-placebo control group (n = 9)
Number of subjects: 24
Study 6130292 — intervention group
Group type: EXPERIMENTAL
Intervention: Naloxone treatment (oral and intravenous)
Number of subjects: 2
Study 6130292 — intervention group
Group type: COMPARATOR
Intervention: Control (large daily doses of laxatives and additional suppositories and enemas)
Number of subjects: 2
Study 3515468 — intervention group
Group type: EXPERIMENTAL
Intervention: Ceftriaxone (1 g or 2 g once daily for 7-12 days)
Number of subjects: 54
Study 3515468 — intervention group
Group type: COMPARATOR
Intervention: Cefotaxime (2 g twice daily for 7-12 days)
Number of subjects: 54
Study 31727194 — intervention group
Group type: EXPERIMENTAL
Intervention: 3 % glycated milk protein
Number of subjects: 15
Study 31727194 — intervention group
Group type: EXPERIMENTAL
Intervention: 20 % glycated milk protein
Number of subjects: 15
Study 31727194 — intervention group
Group type: EXPERIMENTAL
Intervention: 50 % glycated milk protein
Number of subjects: 15
Study 29748142 — intervention group
Group type: EXPERIMENTAL
Intervention: Direct Expert Feedback (DEF)
Number of subjects: 42
Study 29748142 — intervention group
Group type: COMPARATOR
Intervention: Asynchronous Unsupervised Video-Enhanced Feedback (UVF)
Number of subjects: 42
Study 26551403 — intervention group
Group type: EXPERIMENTAL
Intervention: Neurocognitive interventions (cognitive control training and/or transcranial direct current stimulation)
Number of subjects: 0
Study 25560155 — intervention group
Group type: EXPERIMENTAL
Intervention: Isotonic fluid (0.9% NaCl solution in 5% dextrose)
Number of subjects: 60
Study 25560155 — intervention group
Group type: COMPARATOR
Intervention: Hypotonic fluid (0.18% NaCl in 5% dextrose)
Number of subjects: 60
Study 21938763 — intervention group
Group type: EXPERIMENTAL
Intervention: Mathematics Intervention (40-50 hours over 1 year)
Number of subjects: 57
Study 21938763 — intervention group
Group type: EXPERIMENTAL
Intervention: Mathematics Intervention
Number of subjects: 57
Study 21938763 — intervention group
Group type: COMPARATOR
Intervention: Standard Care
Number of subjects: 57
Study 21197498 — intervention group
Group type: EXPERIMENTAL
Intervention: Immediate loading (111 implants, 45 patients)
Number of subjects: 76
Study 21197498 — intervention group
Group type: COMPARATOR
Intervention: Delayed loading (111 implants, 51 patients)
Number of subjects: 76
Study 21197498 — intervention group
Group type: EXPERIMENTAL
Intervention: Immediate implant placement with immediate function (group 1)
Number of subjects: 76
Study 21197498 — intervention group
Group type: EXPERIMENTAL
Intervention: Delayed implant placement with immediate function (group 2)
Number of subjects: 76
Study 21197498 — intervention group
Group type: EXPERIMENTAL
Intervention: Delayed implant placement with delayed function (group 3)
Number of subjects: 76
Study 21197498 — intervention group
Group type: EXPERIMENTAL
Intervention: Delayed implant placement with delayed function (group 4)
Number of subjects: 76
Study 21197498 — intervention group
Group type: EXPERIMENTAL
Intervention: Immediate function implants
Number of subjects: 76
Study 18386572 — intervention group
Group type: EXPERIMENTAL
Intervention: Ningzhi Capsule (NZC) 5 tablets, 3 times a day for 6 months
Number of subjects: 70
Study 18386572 — intervention group
Group type: COMPARATOR
Intervention: Lipanthgl or Simvastatin (control group)
Number of subjects: 70
Study 15766344 — intervention group
Group type: EXPERIMENTAL
Intervention: Flexiblade laryngoscope
Number of subjects: 100
Study 15766344 — intervention group
Group type: COMPARATOR
Intervention: Macintosh laryngoscope
Number of subjects: 100
Study 14508311 — intervention group
Group type: EXPERIMENTAL
Intervention: AEP-monitored group (AAI-guided administration)
Number of subjects: 70
Study 14508311 — intervention group
Group type: EXPERIMENTAL
Intervention: AEP-monitored group
Number of subjects: 70
Study 14508311 — intervention group
Group type: COMPARATOR
Intervention: Control group (standard clinical practice)
Number of subjects: 70
Study 10092691 — intervention group
Group type: EXPERIMENTAL
Intervention: Nedocromil sodium (4 mg, 2 mg/puff, two puffs three times daily)
Number of subjects: 79
Study 10092691 — intervention group
Group type: COMPARATOR
Intervention: Placebo (two puffs three times daily)
Number of subjects: 79
Study 8687370 — intervention group
Group type: EXPERIMENTAL
Intervention: Musical Mood Induction (Depression/Elation)
Number of subjects: 0
Study 1757042 — intervention group
Group type: EXPERIMENTAL
Intervention: 2% MK-507 with 0.5% hydroxyethylcellulose (HEC)
Number of subjects: 24
Study 1757042 — intervention group
Group type: EXPERIMENTAL
Intervention: 2% MK-507 without HEC
Number of subjects: 24
Study 1757042 — intervention group
Group type: COMPARATOR
Intervention: Vehicle with HEC
Number of subjects: 24
Study 1757042 — intervention group
Group type: COMPARATOR
Intervention: Vehicle without HEC
Number of subjects: 24
Study 1757042 — intervention group
Group type: EXPERIMENTAL
Intervention: 2% MK-507 (both formulations)
Number of subjects: 24
Study 6850464 — intervention group
Group type: EXPERIMENTAL
Intervention: BCG administered orally in patients with resectable colon cancer
Number of subjects: 0
Study 6850464 — intervention group
Group type: EXPERIMENTAL
Intervention: BCG administered orally in nonrandomized studies of patients with malignant melanoma and stage IV breast carcinoma
Number of subjects: 0
Study 6850464 — intervention group
Group type: EXPERIMENTAL
Intervention: Selective stimulation of the immune system with NED 137 in advanced gastrointestinal cancer
Number of subjects: 0
Study 6850464 — intervention group
Group type: COMPARATOR
Intervention: BCG administered intraperitoneally along with 5-fluorouracil for gastrointestinal cancer
Number of subjects: 0
Study 30415648 — intervention group
Group type: COMPARATOR
Intervention: Attention Control Training (ACT)
Number of subjects: 50
Study 30415648 — intervention group
Group type: EXPERIMENTAL
Intervention: Bias-contingent Attention Bias Modification (BC-ABM)
Number of subjects: 50
Study 29621811 — intervention group
Group type: EXPERIMENTAL
Intervention: Injected Vitamin D (300,000 units in 1 cc)
Number of subjects: 100
Study 29621811 — intervention group
Group type: COMPARATOR
Intervention: Normal saline (placebo, 1 cc)
Number of subjects: 100
Study 26936298 — intervention group
Group type: EXPERIMENTAL
Intervention: Rituximab
Number of subjects: 49
Study 26936298 — intervention group
Group type: COMPARATOR
Intervention: Conventional therapy
Number of subjects: 49
Study 24585722 — intervention group
Group type: EXPERIMENTAL
Intervention: Bevacizumab-pemetrexed (500 mg/m2)
Number of subjects: 376
Study 24585722 — intervention group
Group type: COMPARATOR
Intervention: Bevacizumab (7.5 mg/kg)
Number of subjects: 376
Study 22272251 — intervention group
Group type: EXPERIMENTAL
Intervention: High-Intensity Exercise (HIE) (75% VO(2)max)
Number of subjects: 15
Study 22272251 — intervention group
Group type: COMPARATOR
Intervention: Sedentary (SED)
Number of subjects: 15
Study 22272251 — intervention group
Group type: COMPARATOR
Intervention: Low-Intensity Exercise (LIE) (40% VO(2)max)
Number of subjects: 15
Study 20873893 — intervention group
Group type: EXPERIMENTAL
Intervention: Group Cognitive-Behavioral (CB) intervention
Number of subjects: 341
Study 20873893 — intervention group
Group type: EXPERIMENTAL
Intervention: CB bibliotherapy
Number of subjects: 341
Study 20873893 — intervention group
Group type: COMPARATOR
Intervention: Supportive expressive intervention
Number of subjects: 341
Study 20873893 — intervention group
Group type: COMPARATOR
Intervention: Brochure control
Number of subjects: 341
Study 20873893 — intervention group
Group type: EXPERIMENTAL
Intervention: Group CB participants
Number of subjects: 341
Study 20873893 — intervention group
Group type: EXPERIMENTAL
Intervention: CB bibliotherapy participants
Number of subjects: 341
Study 17522988 — intervention group
Group type: EXPERIMENTAL
Intervention: Methylphenidate, gradually increasing dosage over two weeks, followed by a similar two-week period of gradually diminishing dosage.
Number of subjects: 0
Study 16386168 — intervention group
Group type: EXPERIMENTAL
Intervention: Telephone intervention
Number of subjects: 85
Study 16386168 — intervention group
Group type: COMPARATOR
Intervention: Minimal intervention (written information, goal-setting, and action plans)
Number of subjects: 85
Study 12167115 — intervention group
Group type: EXPERIMENTAL
Intervention: Omeprazole (OMP) 20 mg once daily
Number of subjects: 56
Study 12167115 — intervention group
Group type: COMPARATOR
Intervention: Famotidine (FAM) 20 mg twice daily
Number of subjects: 56
Study 10559097 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous aspiration of subglottic secretions (CASS)
Number of subjects: 343
Study 10559097 — intervention group
Group type: COMPARATOR
Intervention: Routine postoperative medical care without CASS
Number of subjects: 343
Study 8913711 — intervention group
Group type: EXPERIMENTAL
Intervention: Ondansetron (O) 16 mg 3 times/day
Number of subjects: 21
Study 8913711 — intervention group
Group type: EXPERIMENTAL
Intervention: Ondansetron (O)
Number of subjects: 21
Study 8913711 — intervention group
Group type: COMPARATOR
Intervention: Placebo (P)
Number of subjects: 21
Study 1905438 — intervention group
Group type: EXPERIMENTAL
Intervention: Dextrose 70% injection (D70W) plus 15% amino acids for PN, 25-mL piggybacks, selected drugs added to the PN solution
Number of subjects: 20
Study 1905438 — intervention group
Group type: COMPARATOR
Intervention: D70W plus 10% amino acids, 50- or 100-mL piggybacks
Number of subjects: 20
Study 6393976 — intervention group
Group type: EXPERIMENTAL
Intervention: 1000 mg ASA/d
Number of subjects: 867
Study 6393976 — intervention group
Group type: EXPERIMENTAL
Intervention: 60 mg ASA/d
Number of subjects: 867
Study 6393976 — intervention group
Group type: EXPERIMENTAL
Intervention: 30 mg ASA/d
Number of subjects: 867
Study 6393976 — intervention group
Group type: COMPARATOR
Intervention: No ASA administration (control group)
Number of subjects: 867
Study 30659044 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-carbohydrate food-based diet providing around 800 kcal/day for 8 weeks followed by 4 weeks of weight maintenance
Number of subjects: 30
Study 30659044 — intervention group
Group type: EXPERIMENTAL
Intervention: Healthcare professionals conducting the intervention delivery session
Number of subjects: 30
Study 30659044 — intervention group
Group type: EXPERIMENTAL
Intervention: Participants attending the final follow-up session
Number of subjects: 30
Study 30659044 — intervention group
Group type: EXPERIMENTAL
Intervention: Change in haemoglobin A1c
Number of subjects: 30
Study 30659044 — intervention group
Group type: EXPERIMENTAL
Intervention: Change in weight
Number of subjects: 30
Study 29204869 — intervention group
Group type: EXPERIMENTAL
Intervention: Valerate estradiol 2 mg daily + dihydrogesterone 10 mg daily during luteal phase for 3 months before IVF
Number of subjects: 26
Study 29204869 — intervention group
Group type: COMPARATOR
Intervention: No pre-treatment
Number of subjects: 26
Study 27528065 — intervention group
Group type: EXPERIMENTAL
Intervention: Gut microbiota composition assessment via 16S ribosomal RNA sequencing
Number of subjects: 205
Study 27528065 — intervention group
Group type: EXPERIMENTAL
Intervention: Assessment of butyrate-producing genes via real-time polymerase chain reaction
Number of subjects: 205
Study 27528065 — intervention group
Group type: EXPERIMENTAL
Intervention: Measurement of plasminogen activator inhibitor-1 levels in fasting serum
Number of subjects: 205
Study 27528065 — intervention group
Group type: EXPERIMENTAL
Intervention: Assessment of butyrate production capacity
Number of subjects: 205
Study 27528065 — intervention group
Group type: EXPERIMENTAL
Intervention: Correlation analysis of butyrate kinase expression and Odoribacter abundance
Number of subjects: 205
Study 24038035 — intervention group
Group type: COMPARATOR
Intervention: Lopinavir/ritonavir (LPV/r)
Number of subjects: 116
Study 24038035 — intervention group
Group type: COMPARATOR
Intervention: Efavirenz (EFV)
Number of subjects: 116
Study 22841038 — intervention group
Group type: EXPERIMENTAL
Intervention: Portable monitoring device (Stardust - STD) used at home (STDHome)
Number of subjects: 26
Study 22841038 — intervention group
Group type: EXPERIMENTAL
Intervention: Portable monitoring device (Stardust - STD) used in sleep laboratory (PSG-STDLab)
Number of subjects: 26
Study 22841038 — intervention group
Group type: EXPERIMENTAL
Intervention: Portable monitoring device (Stardust - STD)
Number of subjects: 26
Study 20719811 — intervention group
Group type: EXPERIMENTAL
Intervention: PCQ-infertility questionnaire
Number of subjects: 888
Study 20719811 — intervention group
Group type: EXPERIMENTAL
Intervention: PCQ-infertility subscale 'communication'
Number of subjects: 888
Study 20719811 — intervention group
Group type: EXPERIMENTAL
Intervention: PCQ-infertility subscale 'continuity'
Number of subjects: 888
Study 20719811 — intervention group
Group type: EXPERIMENTAL
Intervention: PCQ-infertility importance item
Number of subjects: 888
Study 20719811 — intervention group
Group type: COMPARATOR
Intervention: Comparison between clinics
Number of subjects: 888
Study 18997657 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate Intensity (MI)
Number of subjects: 20
Study 18997657 — intervention group
Group type: EXPERIMENTAL
Intervention: High Intensity (HI)
Number of subjects: 20
Study 15763055 — intervention group
Group type: EXPERIMENTAL
Intervention: Toubiao Qingfei Decoction (TBQFD) + Western medicines
Number of subjects: 46
Study 15763055 — intervention group
Group type: COMPARATOR
Intervention: Western medicines
Number of subjects: 46
Study 12394288 — intervention group
Group type: EXPERIMENTAL
Intervention: Amisulpride 50 mg/day
Number of subjects: 71
Study 12394288 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 71
Study 10442359 — intervention group
Group type: EXPERIMENTAL
Intervention: uracil/tegafur plus oral calcium folinate (UFT)
Number of subjects: 373
Study 10442359 — intervention group
Group type: COMPARATOR
Intervention: 5‐fluorouracil (5‐FU) plus oral calcium folinate
Number of subjects: 373
Study 8573687 — intervention group
Group type: EXPERIMENTAL
Intervention: 125 mg oral dose of terbinafine
Number of subjects: 16
Study 2105087 — intervention group
Group type: EXPERIMENTAL
Intervention: Nifedipine (n = 25)
Number of subjects: 50
Study 2105087 — intervention group
Group type: COMPARATOR
Intervention: Control (Nitroglycerin, n = 25)
Number of subjects: 50
Study 30465 — intervention group
Group type: EXPERIMENTAL
Intervention: Lorazepam 2.5 mg
Number of subjects: 138
Study 30465 — intervention group
Group type: COMPARATOR
Intervention: Promethazine 50 mg
Number of subjects: 138
Study 31376501 — intervention group
Group type: EXPERIMENTAL
Intervention: Parent-Child Interaction Therapy with Emotion Development module (PCIT-ED)
Number of subjects: 0
Study 31376501 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard Parent-Child Interaction Therapy (PCIT)
Number of subjects: 0